Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
For 2019, 24 EU/EEA countries reported 1 049 confirmed cases of leptospirosis, the highest number in the period from 2015–2019, possibly because of environmental conditions favourable to hosts, and/or increase of activities at risk for infection.